Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024 14

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024 14

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Updated on: January 30,2024 16

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Updated on:January 30,2024 16

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on: January 07,2024 10

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on:January 07,2024 10

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on: March 20,2024 19

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on:March 20,2024 19

Scientists develop a rapid gene-editing screen to find effects of cancer mutations

by Massachusetts Institute of TechnologyDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHTumors can carry mutations in hundreds of different gen

Updated on: March 20,2024 10

Scientists develop a rapid gene-editing screen to find effects of cancer mutations

by Massachusetts Institute of TechnologyDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHTumors can carry mutations in hundreds of different gen

Updated on:March 20,2024 10

New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer

by City of Hope National Medical CenterCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Scientists at City of Hope, a world-renowned independent research and treat

Updated on: April 29,2024 15

New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer

by City of Hope National Medical CenterCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Scientists at City of Hope, a world-renowned independent research and treat

Updated on:April 29,2024 15

New checkpoint gene demonstrates ability to supercharge immune cells against cancer

byUniversity of Minnesota Medical SchoolGraphical abstract. Credit:Med(2022). DOI: 10.1016/j.medj.2022.07.008University of Minnesota researchers and their collaborators at the Nation

Updated on: January 12,2024 10

New checkpoint gene demonstrates ability to supercharge immune cells against cancer

byUniversity of Minnesota Medical SchoolGraphical abstract. Credit:Med(2022). DOI: 10.1016/j.medj.2022.07.008University of Minnesota researchers and their collaborators at the Nation

Updated on:January 12,2024 10

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on: April 29,2024 13

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on:April 29,2024 13

Study finds improved survival for incurable brain tumor, providing 'a crack in the armor'

byUniversity of MichiganA series of brain scans shows a tumor shrinking in response to ONC201. Credit: Michigan MedicineFor the first time, researchers have found a potential drug candidate that

Updated on: January 23,2024 11

Study finds improved survival for incurable brain tumor, providing 'a crack in the armor'

byUniversity of MichiganA series of brain scans shows a tumor shrinking in response to ONC201. Credit: Michigan MedicineFor the first time, researchers have found a potential drug candidate that

Updated on:January 23,2024 11

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on: March 13,2024 15

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on:March 13,2024 15

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on: April 09,2024 20

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on:April 09,2024 20

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on: February 20,2024 17

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on:February 20,2024 17